ஃபைசர் தடுப்பு மருந்துகள் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஃபைசர் தடுப்பு மருந்துகள் ஆராய்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஃபைசர் தடுப்பு மருந்துகள் ஆராய்ச்சி Today - Breaking & Trending Today

Pfizer plans to test coronavirus vaccine booster engineered for South African variant

Pfizer plans to test coronavirus vaccine booster engineered for South African variant
Phil Dormitzer, one of Pfizer s top viral vaccine scientists, said in an interview that he believes the current vaccine is highly likely to still protect against the concerning variant first discovered in South Africa
Reuters | February 19, 2021 | Updated 10:59 IST
A top Pfizer Inc scientist said on Thursday the company is in intensive discussions with regulators to test a booster shot version of its coronavirus vaccine specifically targeted for a highly contagious variant that is spreading widely in South Africa and elsewhere. Phil Dormitzer, one of Pfizer s top viral vaccine scientists, said in an interview that he believes the current vaccine - developed with Germany s BioNTech SE - is highly likely to still protect against the concerning variant first discovered in South Africa. ....

South Africa , South African , Phil Dormitzer , Pfizer Vaccines Research , Pfizer Inc , Drug Administration , Coronavirus Vaccine , Covid 19 Vaccine , Pfizer Coronavirus Vaccine , Coronavirus Vaccine South African Variant , South African Variant Of Coronavirus , South African Covid 19 Variant , South African Coronavirus Variant , Pfizer Coronavirus Vaccine South African Varian , ஃபைசர் தடுப்பு மருந்துகள் ஆராய்ச்சி , ஃபைசர் இன்க் ,

Pfizer plans to test coronavirus vaccine booster engineered for South African variant

Pfizer plans to test coronavirus vaccine booster engineered for South African variant
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

South Africa , South African , Phil Dormitzer , Pfizer Vaccines Research , Pfizer Inc , Drug Administration , ஃபைசர் தடுப்பு மருந்துகள் ஆராய்ச்சி , ஃபைசர் இன்க் ,

Pfizer plans to test COVID-19 vaccine booster engineered for South African variant

3 Min Read
NEW YORK, Feb 18 (Reuters) - A top Pfizer Inc scientist said on Thursday the company is in intensive discussions with regulators to test a booster shot version of its coronavirus vaccine specifically targeted for a highly contagious variant that is spreading widely in South Africa and elsewhere.
Phil Dormitzer, one of Pfizer’s top viral vaccine scientists, said in an interview that he believes the current vaccine - developed with Germany’s BioNTech SE - is highly likely to still protect against the concerning variant first discovered in South Africa.
“We’re not doing that primarily because we think that that means that we’re going to need to change that vaccine,” he said. “It’s primarily to learn how to change strain, both in terms of what we do at the manufacturing level, and especially what the clinical results are. ....

South Africa , South African , Phil Dormitzer , Caroline Humer , Thomson Reuters Trust Principles , Pfizer Vaccines Research , Pfizer Inc , Drug Administration , Michael Erman , Thomson Reuters Trust , Coronavirus Pfizer , Variant Pix , Corporate Events , Bio Therapeutic Drugs Trbc Level 5 , Central Eastern Europe , Company News , Corona Virus , Euro Zone , General News , General Health , Health Medicine , Healthcare Trbc Level 1 , Human Diseases Conditions , Infectious Diseases , Medical Regulation , Biotechnology Amp Medical Research Trbc Level 4 ,

Pfizer plans to test COVID-19 vaccine booster targeting the South African variant

Pfizer plans to test COVID-19 vaccine booster targeting the South African variant
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

South Africa , South African , Pei Yong Shi , Phil Dormitzer , Caroline Humer , Thomson Reuters Trust Principles , Pfizer Vaccines Research , Drug Administration , University Of Texas Medical Branch , Pfizer Inc , Moderna Inc , Texas Medical Branch , Michael Erman , Thomson Reuters Trust , பேய் யோங் ஷி , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் , ஃபைசர் தடுப்பு மருந்துகள் ஆராய்ச்சி , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் மருத்துவ கிளை , ஃபைசர் இன்க் , மாடர்னா இன்க் , டெக்சாஸ் மருத்துவ கிளை , மைக்கேல் அர்மந் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ,

UPDATE 1-Pfizer plans to test COVID-19 vaccine booster targeting the South African variant

UPDATE 1-Pfizer plans to test COVID-19 vaccine booster targeting the South African variant
Reuters
2/18/2021
By Michael Erman
NEW YORK, Feb 18 (Reuters) - A top Pfizer Inc scientist said on Thursday the company is in intensive discussions with regulators to test a booster shot version of its coronavirus vaccine specifically targeted for a highly contagious variant that is spreading widely in South Africa and elsewhere.
A laboratory study released on Wednesday suggested that the South African virus variant may reduce protective antibodies elicited by the Pfizer/BioNTech vaccine by two-thirds, but it is not clear how much that reduces the shot s effectiveness against this version of the pathogen. ....

South Africa , South African , Pei Yong Shi , Phil Dormitzer , Caroline Humer , Pfizer Vaccines Research , Pfizer Inc , Moderna Inc , Drug Administration , University Of Texas Medical Branch , Texas Medical Branch , Michael Erman Editing , Bill Berkrot , பேய் யோங் ஷி , ஃபைசர் தடுப்பு மருந்துகள் ஆராய்ச்சி , ஃபைசர் இன்க் , மாடர்னா இன்க் , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் மருத்துவ கிளை , டெக்சாஸ் மருத்துவ கிளை , மைக்கேல் அர்மந் திருத்துதல் ,